vVARDIS Holding AG (VVVV)
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Specialties
vVARDIS HOLDING AG Class A
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 15.75 | 16.29 | 15.68 | 15.80 | 161,717 |
| Nov 16, 2026 | 16.07 | 16.95 | 15.95 | 16.00 | 676,352 |
| Nov 13, 2026 | 14.00 | 16.94 | 14.00 | 16.50 | 3,782,934 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Grant/Award | 36.5K | -- | Nov 13, 2026 | |
| Director | Other | 701.8K | -- | Nov 13, 2026 | |
| Director | Other | 701.8K | -- | Nov 13, 2026 | |
| Director | Other | 166.3K | -- | Nov 13, 2026 | |
| Director | Other | 166.3K | -- | Nov 13, 2026 | |
| CFO and Chief People Officer | Other | 733.6K | -- | Nov 13, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Abivardi Bronner Haleh Co-CEO, Co-Founder & Co-Chair, Director | 10.4M | 5.7% | FORM 4 |
Abivardi Signer Golnar Co-CEO, Co-Founder & Co-Chair, Director | 10.4M | 5.7% | FORM 4 |
Rondot Thomas CFO and Chief People Officer | 784.7K | 0.4% | FORM 4 |
Stark Juergen M. Director | 701.8K | 0.4% | FORM 4 |
Zur Nieden Clifford Director | 36.5K | 0.0% | FORM 4 |
Insiders
- Zur Nieden CliffordDirector
- Stark Juergen M.Director
- Rondot ThomasCFO and Chief People Officer
- Abivardi Bronner HalehCo-CEO, Co-Founder & Co-Chair
- Abivardi Signer GolnarCo-CEO, Co-Founder & Co-Chair
vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States.
The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel.
The company was incorporated in 2020 and is based in Zug, Switzerland. vVARDIS Holding AG operates as a subsidiary of VVARDIS Investment Holding AG.
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
30d Avg
1.54M
60d Avg
1.54M
90d Avg
1.54M
vVARDIS Holding AG (NYSE: VVVV) traded at $15.80 on Nov 17, 2026, down 1.25% from the previous close of $16.00. The company is in the Healthcare sector (Medical - Specialties).